Plus, news about Rivus and Crown Labs:
Two Chinese biotechs file for stock listings in Hong Kong: Shanghai Bao Pharmaceuticals and Sichuan Biokin Pharmaceutical join a queue of Chinese drug developers looking to float their ...
↧
